This equity is a long term play.  The patented product works. 

There is no debt.

There is clear control by a single shareholder.

I have no expectation of 'large' sales in 2022, at all.  Large companies want govt financing for the purchase. Govt financing takes literally years.  Large companies would buy, if they had to buy replacement equipment. There is a sound business case to get PYR product when there will be the need to replace old equipment. If old equipment does not need to be replaced, why buy? 

I don't expect significant sales for years, unless there is govt financing made available to the large companies.

The HPQ connection is the earlier prize. Things should begin around September/October 2022 when the results come in from the third party testing for HPQ. Leaving room for modification after the testing results, my own timeline is 2023 Q1 when HPQ marketing begins. 

The point is that PYR has never been a 'regular' equity for me. I am on a five year hold. I like the technology. I like the management and operation of PYR. 

For people who go for 'what have you done for me lately', or 'please explain why the share price is low', I recommend selling PYR holdings. Just sell. 

Longterm players should have their day. Print this message out, store it, and come back to it in a couple years.